Home -> Law Blog Directory -> Personal Injury Law Blogs -> Philadelphia Personal Injury Lawyer
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Philadelphia Personal Injury LawyerAnemia Drugs Given Stronger Warnings
By Jamie Sheller
The makers of Aranesp, Epogen and Procrit have recently been advised by the FDA to expand its black box warnings. The new warnings indicate the risks of death and tumor growth when used by cancer patients with early stage breast cancer or cancer in the head and neck. Aransep, Epogen and Procrit are popular drugs used to treat the blood disorder anemia in patients with kidney failure and those on chemotherapy. http://www.fda.gov/cder/drug/advisory/RHE2007.htm If you, or a family member has been injured by this drug, contact Sheller PC to get more information about your legal rights. We have a team of experienced attorneys who are willing to assist you in every aspect of your case.
Full post as published by Philadelphia Personal Injury Lawyer on March 26, 2008 (boomark / email).
Darvon
Other Propoxyphene-Containing Meds to Require Stronger Warnings
Acetaminophen
FDA Wants New Safety Warnings
CellCept
Roche Issues Changes to Warnings and Adverse Events
Cipro
The FDA is seeking to add black box warnings of the risk of tendon rupture associated with Cipro and Levaquin.
The ruptures can involve Achilles tendon, shoulder, hand, bicep or thumb tendons, and is especially increased in patients older than 60, or people who have received kidney, heart or lung transplants, as well as people on steroid therapy...
GlaxoSmithKline Pays $750 Million Over Defective Drugs
GlaxoSmithKline Pays $750 Million Over Defective Drugs
Fake Drugs
Life Threatening Incidents

FDA Adds Additional Black-Box Warnings to Anemia Drugs
FDA Orders Labeling Changes for Anemia Drugs
Anemia drugs may have dangerous side effects
F.D.A. Orders Stronger Warnings on Arthritis Drugs
FDA Adds Warnings on Arthritis Drugs
Study: Anemia Drugs May Pose Death Risk







